Analystreport

Constellation Pharmaceuticals Inc (NASDAQ: CNST) is now covered by analysts at Cann. They set an "outperform" rating and a $21.00 price target on the stock.

Constellation Pharmaceuticals, Inc  (CNST) 
Last constellation pharmaceuticals, inc earnings: 3/10 04:12 pm Check Earnings Report